Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
---|---|---|---|---|---|---|
Filed 2023-11-30 16:53 Tx date 2023-11-30 |
$IFX
Imaflex Inc. |
Ripplinger, John
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$19,620
+25,000 vol $0.78 each |
727,300 | |
Filed 2023-11-30 16:28 Tx date 2023-11-30 |
$IFX
Imaflex Inc. |
Ripplinger, John
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$19,685
+25,000 vol $0.79 each |
||
Filed 2023-11-30 16:25 Tx date 2023-11-30 |
$IFX
Imaflex Inc. |
Ripplinger, John
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$19,750
+25,000 vol $0.79 each |
702,300 | |
Filed 2023-06-08 19:45 Tx date 2023-06-05 |
$IFX
Imaflex Inc. |
Ripplinger, John
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$166,500
+150,000 vol $1.11 each |
677,300 | |
Filed 2023-06-08 19:43 Tx date 2023-06-05 |
$IFX
Imaflex Inc. |
Ripplinger, John
5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-166,500
-150,000 vol $1.11 each |
150,000 | |
Filed 2023-06-02 16:01 Tx date 2023-05-30 |
$IFX
Imaflex Inc. |
Ripplinger, John
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+150,000 vol |
300,000 | |
Filed 2021-12-15 16:06 Tx date 2021-12-14 |
$IFX
Imaflex Inc. |
Ripplinger, John
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-55,413
-42,300 vol $1.31 each |
527,300 | |
Filed 2021-12-15 16:04 Tx date 2021-12-13 |
$IFX
Imaflex Inc. |
Ripplinger, John
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-655.00
-500 vol $1.31 each |
569,600 | |
Filed 2021-12-13 16:36 Tx date 2021-12-10 |
$IFX
Imaflex Inc. |
Ripplinger, John
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-660.00
-500 vol $1.32 each |
570,100 | |
Filed 2021-12-13 16:35 Tx date 2021-12-10 |
$IFX
Imaflex Inc. |
Ripplinger, John
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-2,882
-2,200 vol $1.31 each |
570,600 | |
Filed 2021-09-23 14:21 Tx date 2021-09-22 |
$IFX
Imaflex Inc. |
Ripplinger, John
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-3,014
-2,200 vol $1.37 each |
572,800 | |
Filed 2021-08-30 10:44 Tx date 2021-08-25 |
$IFX
Imaflex Inc. |
Ripplinger, John
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$210,000
+500,000 vol $0.42 each |
575,000 | |
Filed 2021-08-30 10:37 Tx date 2021-08-25 |
$IFX
Imaflex Inc. |
Ripplinger, John
5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-210,000
-500,000 vol $0.42 each |
150,000 | |
Filed 2019-09-26 12:32 Tx date 2019-09-25 |
$IFX
Imaflex Inc. |
Ripplinger, John
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$7,750
+12,500 vol $0.62 each |
75,000 | |
Filed 2019-09-26 12:30 Tx date 2019-09-24 |
$IFX
Imaflex Inc. |
Ripplinger, John
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$7,350
+12,500 vol $0.59 each |
62,500 | |
Filed 2019-08-28 16:18 Tx date 2019-08-28 |
$IFX
Imaflex Inc. |
Ripplinger, John
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$24,500
+50,000 vol $0.49 each |
50,000 | |
Filed 2019-08-28 16:17 Tx date 2016-09-06 |
$IFX
Imaflex Inc. |
Ripplinger, John
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2017-11-30 Tx date 2017-11-28 |
$IFX
Imaflex Inc. |
Ripplinger, John
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+150,000 vol |
650,000 | |
Filed 2016-09-08 Tx date 2016-09-06 |
$IFX
Imaflex Inc. |
Ripplinger, John
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2016-09-08 Tx date 2016-09-06 |
$IFX
Imaflex Inc. |
Ripplinger, John
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+500,000 vol |
500,000 | |
Filed 2015-12-09 Tx date 2013-12-03 |
$APO
Acasti Pharma Inc. |
Ripplinger, John
5 - Senior Officer of Issuer
Direct Ownership
|
Warrants (Units)
10 - Acquisition or disposition in the public market
|
$12,500
+10,000 vol $1.25 each |
||
Filed 2015-12-09 Tx date 2015-10-15 |
$APO
Acasti Pharma Inc. |
Ripplinger, John
5 - Senior Officer of Issuer
Direct Ownership
|
Warrants (Units)
37 - Stock split or consolidation
|
-9,000 vol |
||
Filed 2015-12-09 Tx date 2015-10-15 |
$APO
Acasti Pharma Inc. |
Ripplinger, John
5 - Senior Officer of Issuer
Direct Ownership
|
Warrants (Units)
37 - Stock split or consolidation
|
-9,000 vol |
||
Filed 2015-12-09 Tx date 2013-12-03 |
$APO
Acasti Pharma Inc. |
Ripplinger, John
5 - Senior Officer of Issuer
Direct Ownership
|
Warrants (Units)
15 - Acquisition or disposition under a prospectus
|
+10,000 vol |
||
Filed 2015-12-09 Tx date 2013-12-03 |
$APO
Acasti Pharma Inc. |
Ripplinger, John
5 - Senior Officer of Issuer
Direct Ownership
|
Warrants (Units)
15 - Acquisition or disposition under a prospectus
|
+10,000 vol |
||
Filed 2015-12-09 Tx date 2013-12-03 |
$APO
Acasti Pharma Inc. |
Ripplinger, John
5 - Senior Officer of Issuer
Direct Ownership
|
Warrants (Units)
15 - Acquisition or disposition under a prospectus
|
+10,000 vol |
10,000 | |
Filed 2015-11-03 Tx date 2015-10-15 |
$APO
Acasti Pharma Inc. |
Ripplinger, John
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares (Actions de catégorie A)
37 - Stock split or consolidation
|
-18,000 vol |
2,000 | |
Filed 2015-11-03 Tx date 2015-10-15 |
$APO
Acasti Pharma Inc. |
Ripplinger, John
5 - Senior Officer of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
-185,400 vol |
20,600 | |
Filed 2015-11-03 Tx date 2015-10-15 |
$NTB
Neptune Technologies & Bioressources Inc. |
Ripplinger, John
5 - Senior Officer of Issuer
Direct Ownership
|
Call-options
37 - Stock split or consolidation
|
-22,500 vol |
2,500 | |
Filed 2015-11-03 Tx date 2015-10-15 |
$APO
Acasti Pharma Inc. |
Ripplinger, John
5 - Senior Officer of Issuer
Direct Ownership
|
Warrants (Units)
37 - Stock split or consolidation
|
-9,000 vol |
1,000 | |
Filed 2015-10-22 Tx date 2015-10-16 |
$NTB
Neptune Technologies & Bioressources Inc. |
Ripplinger, John
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$77,500
+50,000 vol $1.55 each |
||
Filed 2015-10-22 Tx date 2015-10-16 |
$NTB
Neptune Technologies & Bioressources Inc. |
Ripplinger, John
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$77,500
+50,000 vol $1.55 each |
228,000 | |
Filed 2015-10-21 Tx date 2015-10-16 |
$NTB
Neptune Technologies & Bioressources Inc. |
Ripplinger, John
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$77,500
+50,000 vol $1.55 each |
228,000 | |
Filed 2015-06-17 Tx date 2015-06-15 |
$NTB
Neptune Technologies & Bioressources Inc. |
Ripplinger, John
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$4,050
+2,500 vol $1.62 each |
15,015 | |
Filed 2015-06-17 Tx date 2015-06-15 |
$APO
Acasti Pharma Inc. |
Ripplinger, John
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares (Actions de catégorie A)
57 - Exercise of rights
|
$900.00
+2,500 vol $0.36 each |
20,000 | |
Filed 2015-06-16 Tx date 2015-06-15 |
$APO
Acasti Pharma Inc. |
Ripplinger, John
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
$-900.00
-2,500 vol $0.36 each |
0 | |
Filed 2015-06-16 Tx date 2015-06-15 |
$NTB
Neptune Technologies & Bioressources Inc. |
Ripplinger, John
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
$-4,050
-2,500 vol $1.62 each |
0 | |
Filed 2015-06-08 Tx date 2015-06-01 |
$APO
Acasti Pharma Inc. |
Ripplinger, John
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$43,200
+96,000 vol $0.45 each |
206,000 | |
Filed 2015-06-08 Tx date 2015-06-01 |
$NTB
Neptune Technologies & Bioressources Inc. |
Ripplinger, John
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$46,200
+28,000 vol $1.65 each |
178,000 |